|
Investment in wholly owned subsidiary, Yellowstone Fine Chemicals Private Limited ("YFCPL") for part-financing its capital expenditure requirements in relation to the setting up of manufacturing facility for fluorospecialty Chemicals("Proposed") |
Purchase of plant and machinery for augmenting infrastructure development at SI Manufacturing Facility |
|
Investment in YFCPL for funding its working capital requirements |
Prepayment or repayment of all or a portion of certain outstanding borrowings availed by the company and wholly owned subsidiary, Viva Lifesciences Private Limited ("VLPL") |
|
Funding capital expenditure requirements for expansion of SI Manufacturing Facility ("Proposed Expansion") |
General corporate purposes |
|
Funding working capital requirements of the company | |